Wu-Wei Lai

Associate Professor

  • 1872 Citations
  • 26 h-Index
1990 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile


  • 1984, The degree of China Medical University

Research Interests

  • Lung - cancer


  • 1993/08~2001/07 Lecturer, National Cheng Kung University
  • 2002~present Associate professor, Deparment of Surgery, College of Medicine, National Cheng Kung University

Fingerprint Dive into the research topics where Wu-Wei Lai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 56 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Caustics Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Medicine & Life Sciences
Malignant Pleural Effusion Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Taiwan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2018

Research Output 1990 2019

1 Citation (Scopus)

AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression

Liao, S. Y., Kuo, I. Y., Chen, Y. T., Liao, P. C., Liu, Y. F., Wu, H. Y., Lai, W. W. & Wang, Y. C., 2019 Oct 10, In : Oncogene. 38, 41, p. 6723-6736 14 p.

Research output: Contribution to journalArticle

Protein Stability
Lung Neoplasms
Cyclin D1
Chromatin Immunoprecipitation
1 Citation (Scopus)
Open Access
Lung Neoplasms
Quality of Life
Drug Therapy
12 Citations (Scopus)

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Lin, C. Y., Hwang, J. S., Wang, W. C., Lai, W. W., Su, W. C., Wu, T. Y., Yao, G. & Wang, J. D., 2019 Jan, In : Journal of the Formosan Medical Association. 118, 1P2, p. 215-222 8 p.

Research output: Contribution to journalArticle

Statistical Factor Analysis

Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

Su, P. L., Yang, S. C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W. Y., Tseng, Y. L., Lai, W. W., Ho, C. L., Lin, C. C. & Su, W. C., 2019 Oct 1, In : Cancer medicine. 8, 13, p. 5939-5947 9 p.

Research output: Contribution to journalArticle

Open Access
Disease-Free Survival
2 Citations (Scopus)
Open Access
Esophageal Neoplasms
DNA Repair
DNA Damage